Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3518-3529

  Sriskantharajah, Srividya ^a   Gückel, Eva ^a   Tsakiri, Niki ^b   Kierdorf, Katrin ^c   Brender, Christine ^a   Ben Addi, Abduelhakem ^a   Veldhoen, Marc ^a   Tsichlis, Philip N ^d   Stockinger, Brigitta ^a   O'Garra, Anne ^a   Prinz, Marco ^c   Kollias, George ^b   Ley, Steven C ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^c UNIVERSITY OF FREIBURG   (Germany)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE KINASES; MICE; MICE, TRANSGENIC; MICROGLIA; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84898657149     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300172     Document Type: Article

References (53)

1. Gantke, T., S. Sriskantharajah, and S. C. Ley. 2011. Regulation and function of TPL-2, an IkB kinase-regulated MAP kinase kinase kinase. Cell Res. 21: 131-145.
2. Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J.-H. Lin, C. Patriotis, N. A. Jenkins, N. G. Copeland, G. Kollias, and P. N. Tsichlis. 2000. TNF-A induction by LPS is regulated posttranscriptionally via a Tpl2/ ERK-dependent pathway. Cell 103: 1071-1083.
3. Eliopoulos, A. G., C.-C. Wang, C. D. Dumitru, and P. N. Tsichlis. 2003. Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J. 22: 3855-3864.
4. Mielke, L. A., K. L. Elkins, L. Wei, R. Starr, P. N. Tsichlis, J. J. O'Shea, and W. T. Watford. 2009. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1b production. J. Immunol. 183: 7984-7993.
5. Kontoyiannis, D., G. Boulougouris, M. Manoloukos, M. Armaka, M. Apostolaki, T. T. Pizarro, A. Kotlyarov, I. Forster, R. A. Flavell, M. Gaestel, et al. 2002. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196: 1563-1574.
6. George, D., and A. Salmeron. 2009. Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease. Curr. Top. Med. Chem. 9: 611-622.
7. Watford, W. T., C.-C. Wang, C. Tsatsanis, L. A. Mielke, A. G. Eliopoulos, C. Daskalakis, N. Charles, S. Odom, J. Rivera, J. O'Shea, and P. N. Tsichlis. 2010. Ablation of tumor progression locus 2 promotes a type 2 Th cell response in ovalbumin-immunized mice. J. Immunol. 184: 105-113.
8. Watford, W. T., B. D. Hissong, L. R. Durant, H. Yamane, L. M. Muul, Y. Kanno, C. M. Tato, H. L. Ramos, A. E. Berger, L. Mielke, et al. 2008. Tpl2 kinase regulates T cell interferon-g production and host resistance to Toxoplasma gondii. J. Exp. Med. 205: 2803-2812.
9. Glimcher, L. H., and K. M. Murphy. 2000. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 14: 1693-1711.
10. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27: 485-517.
11. Becher, B., and B. M. Segal. 2011. TH17 cytokines in autoimmune neuro-inflammation. Curr. Opin. Immunol. 23: 707-712.
12. Krishnamoorthy, G., and H. Wekerle. 2009. EAE: an immunologist's magic eye. Eur. J. Immunol. 39: 2031-2035.
13. Denic, A., A. J. Johnson, A. J. Bieber, A. E. Warrington, M. Rodriguez, and I. Pirko. 2011. The relevance of animal models in multiple sclerosis research. Pathophysiology 18: 21-29.
14. Papoutsopoulou, S., A. Symons, T. Tharmalingham, M. P. Belich, F. Kaiser, D. Kioussis, A. O'Garra, V. Tybulewicz, and S. C. Ley. 2006. ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses. Nat. Immunol. 7: 606-615.
15. Dann, A., H. Poeck, A. L. Croxford, S. Gaupp, K. Kierdorf, M. Knust, D. Pfeifer, C. Maihoefer, S. Endres, U. Kalinke, et al. 2012. Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat. Neurosci. 15: 98-106.
16. Sriskantharajah, S., M. P. Belich, S. Papoutsopoulou, J. Janzen, V. Tybulewicz, B. Seddon, and S. C. Ley. 2009. Proteolysis of NF-kB1 p105 is essential for T cell antigen receptor-induced proliferation. Nat. Immunol. 10: 38-47.
17. Boonstra, A., C. Asselin-Paturel, M. Gilliet, C. Crain, G. Trinchieri, Y. J. Liu, and A. O'Garra. 2003. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197: 101-109.
18. Veldhoen, M., K. Hirota, A. M.Westendorf, J. Buer, L. Dumoutier, J.-C. Renauld, and B. Stockinger. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-109.
19. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFb in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
20. Kang, Z., C. Z. Altuntas, M. F. Gulen, C. Liu, N. Giltiay, H. Qin, L. Liu, W. Qian, R. M. Ransohoff, C. Bergmann, et al. 2010. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32: 414-425.
21. Chung, Y., S. H. Chang, G. J. Martinez, X. O. Yang, R. Nurieva, H. S. Kang, L. Ma, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
22. Bettelli, E., T. Korn, M. Oukka, and V. K. Kuchroo. 2008. Induction and effector functions of TH17 cells. Nature. 453: 1051-1057.
23. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
24. Yang, X. O., B. P. Pappu, R. Nurieva, A. Akimzhanov, H. S. Kang, Y. Chung, L. Ma, B. Shah, A. D. Panopoulos, K. S. Schluns, et al. 2008. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORa and RORg. Immunity 28: 29-39.
25. McGeachy, M. J., and S. M. Anderton. 2005. Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis. Cytokine 32: 81-84.
26. Wilson, E. H., W. Weninger, and C. A. Hunter. 2010. Trafficking of immune cells in the central nervous system. J. Clin. Invest. 120: 1368-1379.
27. Kaiser, F., D. Cook, S. Papoutsopoulou, R. Rajsbaum, X. Wu, H. T. Yang, S. Grant, P. Ricciardi-Castagnoli, P. N. Tsichlis, S. C. Ley, and A. O'Garra. 2009. TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells. J. Exp. Med. 206: 1863-1871.
28. Brereton, C. F., C. E. Sutton, S. J. Lalor, E. C. Lavelle, and K. H. G. Mills. 2009. Inhibition of ERK MAPK suppresses IL-23-and IL-1-driven IL-17 production and attenuates autoimmune disease. J. Immunol. 183: 1715-1723.
29. Barr, T. A., P. Shen, S. Brown, V. Lampropoulou, T. Roch, S. Lawrie, B. Fan, R. A. O'Connor, S. M. Anderton, A. Bar-Or, et al. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209: 1001-1010.
30. Matsushita, T., K. Yanaba, J.-D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
31. Anderton, S. M., and S. Fillatreau. 2008. Activated B cells in autoimmune diseases: the case for a regulatory role. Nat. Clin. Pract. Rheumatol. 4: 657-666.
32. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
33. Banerjee, A., R. Gugasyan, M. McMahon, and S. Gerondakis. 2006. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. USA 103: 3274-3279.
34. Prendergast, C. T., and S. M. Anderton. 2009. Immune cell entry to central nervous system: current understanding and prospective therapeutic targets. Endocr. Metab. Immune Disord. Drug Targets 9: 315-327.
35. Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
36. Zepp, J., L. Wu, and X. Li. 2011. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 32: 232-239.
37. Heppner, F. L., M. Greter, D. Marino, J. Falsig, G. Raivich, N. Hövelmeyer, A. Waisman, T. Rulicke, M. Prinz, J. Priller, et al. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11: 146-152.
38. van Loo, G., R. De Lorenzi, H. Schmidt, M. Huth, A. Mildner, M. Schmidt-Supprian, H. Lassmann, M. R. Prinz, and M. Pasparakis. 2006. Inhibition of transcription factor NF-kB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 7: 954-961.
39. Chastain, E. M. L., D. S. Duncan, J. M. Rodgers, and S. D. Miller. 2011. The role of antigen presenting cells in multiple sclerosis. Biochim. Biophys. Acta 1812: 265-274.
40. Wang, X., M. Deckert, N. T. Xuan, G. Nishanth, S. Just, A. Waisman, M. Naumann, and D. Schluter. 2013. Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-kB and STAT1-dependent. Acta Neuropathol. 126: 711-724.
41. Yang, H. T., S. Papoutsopoulou, M. Belich, C. Brender, J. Janzen, T. Gantke, M. Handley, and S. C. Ley. 2012. Coordinate regulation of TPL-2 and NF-kB signaling in macrophages by NF-kB1 p105. Mol. Cell. Biol. 32: 3438-3451.
42. Lang, V., A. Symons, S. J. Watton, J. Janzen, Y. Soneji, S. Beinke, S. Howell, and S. C. Ley. 2004. ABIN-2 forms a ternary complex with TPL-2 and NF-kB1 p105 and is essential for TPL-2 protein stability. Mol. Cell. Biol. 24: 5235-5248.
43. Salmeron, A., T. B. Ahmad, G. W. Carlile, D. Pappin, R. P. Narsimhan, and S. C. Ley. 1996. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15: 817-826.
44. Prinz, M., H. Schmidt, A. Mildner, K.-P. Knobeloch, U.-K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28: 675-686.
45. Prinz, M., and K.-P. Knobeloch. 2012. Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system. Front. Immunol. 3: 67.
46. Kleinnijenhuis, J., M. Oosting, L. A. B. Joosten, M. G. Netea, and R. Van Crevel. 2011. Innate immune recognition of Mycobacterium tuberculosis. Clin. Dev. Immunol. 2011: 405310.
47. Marta, M. 2009. Toll-like receptors in multiple sclerosis mouse experimental models. Ann. N. Y. Acad. Sci. 1173: 458-462.
48. Prinz, M., J. Priller, S. S. Sisodia, and R. M. Ransohoff. 2011. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 13: 1227-1235.
49. Goldmann, T., P. Wieghofer, P. F. Muller, Y. Wolf, D. Varol, S. Yona, S. M. Brendecke, K. Kierdorf, O. Staszewski, M. Datta, et al. 2013. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat. Neurosci. 16: 1618-1626.
50. Beinke, S., M. J. Robinson, M. Hugunin, and S. C. Ley. 2004. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkB kinase-induced proteolysis of NF-kB1 p105. Mol. Cell. Biol. 24: 9658-9667.
51. Waterfield, M.,W. Jin,W. Reiley, M. Y. Zhang, and S.-C. Sun. 2004. IkB kinase is an essential component of the Tpl2 signaling pathway. Mol. Cell. Biol. 24: 6040-6048.
52. Roget, K., A. Ben-Addi, A. Mambole-Dema, T. Gantke, J. Janzen, H.-T. Yang, N. Shpiro, N. Morrice, D. Abbott, and S. C. Ley. 2012. IkB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400. Mol. Cell. Biol. 32: 4684-4690.
53. Sawcer, S., G. Hellenthal, M. Pirinen, C. C. Spencer, N. A. Patsopoulos, L. Moutsianas, A. Dilthey, Z. Su, C. Freeman, S. E. Hunt, et al International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.